- Home
- VIVS vs NUWE Comparison
VIVS vs NUWE Comparison
Compare VIVS & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- NUWE
- Stock Information
- Founded
- VIVS 2007
- NUWE 1999
- Country
- VIVS United States
- NUWE United States
- Employees
- VIVS N/A
- NUWE N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VIVS Health Care
- NUWE Health Care
- Exchange
- VIVS Nasdaq
- NUWE Nasdaq
- Market Cap
- VIVS 4.7M
- NUWE 3.9M
- IPO Year
- VIVS N/A
- NUWE N/A
- Fundamental
- Price
- VIVS $3.64
- NUWE $3.97
- Analyst Decision
- VIVS
- NUWE
- Analyst Count
- VIVS 0
- NUWE 0
- Target Price
- VIVS N/A
- NUWE N/A
- AVG Volume (30 Days)
- VIVS 868.7K
- NUWE 192.1K
- Earning Date
- VIVS 11-07-2025
- NUWE 11-10-2025
- Dividend Yield
- VIVS N/A
- NUWE N/A
- EPS Growth
- VIVS N/A
- NUWE N/A
- EPS
- VIVS N/A
- NUWE N/A
- Revenue
- VIVS $142,000.00
- NUWE $8,318,000.00
- Revenue This Year
- VIVS $42.38
- NUWE $6.53
- Revenue Next Year
- VIVS $15.42
- NUWE $51.63
- P/E Ratio
- VIVS N/A
- NUWE N/A
- Revenue Growth
- VIVS 94.52
- NUWE N/A
- 52 Week Low
- VIVS $1.41
- NUWE $3.74
- 52 Week High
- VIVS $21.96
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- VIVS 62.00
- NUWE 31.11
- Support Level
- VIVS $3.29
- NUWE $3.74
- Resistance Level
- VIVS $5.30
- NUWE $5.23
- Average True Range (ATR)
- VIVS 0.63
- NUWE 0.33
- MACD
- VIVS 0.16
- NUWE 0.14
- Stochastic Oscillator
- VIVS 52.16
- NUWE 15.23
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.